-
1
-
-
37449012509
-
Clinical impact of molecular analysis on thyroid cancer management
-
vii
-
Wreesmann VB, Singh B 2008 Clinical impact of molecular analysis on thyroid cancer management. Surg Oncol Clin N Am 17:1-35, vii.
-
(2008)
Surg Oncol Clin N Am
, vol.17
, pp. 1-35
-
-
Wreesmann, V.B.1
Singh, B.2
-
2
-
-
80053150200
-
Molecular genetics and diagnosis of thyroid cancer
-
Nikiforov YE, Nikiforova MN 2011 Molecular genetics and diagnosis of thyroid cancer. Nat Rev Endocrinol 7:569-580.
-
(2011)
Nat Rev Endocrinol
, vol.7
, pp. 569-580
-
-
Nikiforov, Y.E.1
Nikiforova, M.N.2
-
3
-
-
84865208676
-
Preoperative diagnosis of benign thyroid nodules with indeterminate cytology
-
Alexander EK, Kennedy GC, Baloch ZW, Cibas ES, Chudova D, Diggans J, Friedman L, Kloos RT, LiVolsi VA, Mandel SJ, Raab SS, Rosai J, Steward DL, Walsh PS, Wilde JI, Zeiger MA, Lanman RB, Haugen BR 2012 Preoperative diagnosis of benign thyroid nodules with indeterminate cytology. N Engl J Med 367:705-715.
-
(2012)
N Engl J Med
, vol.367
, pp. 705-715
-
-
Alexander, E.K.1
Kennedy, G.C.2
Baloch, Z.W.3
Cibas, E.S.4
Chudova, D.5
Diggans, J.6
Friedman, L.7
Kloos, R.T.8
LiVolsi, V.A.9
Mandel, S.J.10
Raab, S.S.11
Rosai, J.12
Steward, D.L.13
Walsh, P.S.14
Wilde, J.I.15
Zeiger, M.A.16
Lanman, R.B.17
Haugen, B.R.18
-
4
-
-
84887472968
-
Targeted next-generation sequencing panel (ThyroSeq) for detection of mutations in thyroid cancer
-
Nikiforova MN, Wald AI, Roy S, Durso MB, Nikiforov YE 2013 Targeted next-generation sequencing panel (ThyroSeq) for detection of mutations in thyroid cancer. J Clin Endocrinol Metab 98:E1852-1860.
-
(2013)
J Clin Endocrinol Metab
, vol.98
, pp. E1852-1860
-
-
Nikiforova, M.N.1
Wald, A.I.2
Roy, S.3
Durso, M.B.4
Nikiforov, Y.E.5
-
5
-
-
84913605660
-
Highly accurate diagnosis of cancer in thyroid nodules with follicular neoplasm/suspicious for a follicular neoplasm cytology by ThyroSeq v2 next-generation sequencing assay
-
Nikiforov YE, Carty SE, Chiosea SI, Coyne C, Duvvuri U, Ferris RL, Gooding WE, Hodak SP, LeBeau SO, Ohori NP, Seethala RR, Tublin ME, Yip L, Nikiforova MN 2014 Highly accurate diagnosis of cancer in thyroid nodules with follicular neoplasm/suspicious for a follicular neoplasm cytology by ThyroSeq v2 next-generation sequencing assay. Cancer 120:3627-3634.
-
(2014)
Cancer
, vol.120
, pp. 3627-3634
-
-
Nikiforov, Y.E.1
Carty, S.E.2
Chiosea, S.I.3
Coyne, C.4
Duvvuri, U.5
Ferris, R.L.6
Gooding, W.E.7
Hodak, S.P.8
LeBeau, S.O.9
Ohori, N.P.10
Seethala, R.R.11
Tublin, M.E.12
Yip, L.13
Nikiforova, M.N.14
-
6
-
-
66349098309
-
Mutational profile of advanced primary and metastatic radioactive iodine-refractory thyroid cancers reveals distinct pathogenetic roles for BRAF PIK3CA, and AKT1
-
Ricarte-Filho JC, Ryder M, Chitale DA, RiveraM, Heguy A, Ladanyi M, Janakiraman M, Solit D, Knauf JA, Tuttle RM, Ghossein RA, Fagin JA 2009 Mutational profile of advanced primary and metastatic radioactive iodine-refractory thyroid cancers reveals distinct pathogenetic roles for BRAF, PIK3CA, and AKT1. Cancer Res 69:4885-4893.
-
(2009)
Cancer Res
, vol.69
, pp. 4885-4893
-
-
Ricarte-Filho, J.C.1
Ryder, M.2
Chitale, D.A.3
Riveram Heguy, A.4
Ladanyi, M.5
Janakiraman, M.6
Solit, D.7
Knauf, J.A.8
Tuttle, R.M.9
Ghossein, R.A.10
Fagin, J.A.11
-
7
-
-
84882805198
-
Highly prevalent TERT promoter mutations in aggressive thyroid cancers
-
Liu X, Bishop J, Shan Y, Pai S, Liu D, Murugan AK, Sun H, El-Naggar AK, Xing M 2013 Highly prevalent TERT promoter mutations in aggressive thyroid cancers. Endocr Relat Cancer 20:603-610.
-
(2013)
Endocr Relat Cancer
, vol.20
, pp. 603-610
-
-
Liu, X.1
Bishop, J.2
Shan, Y.3
Pai, S.4
Liu, D.5
Murugan, A.K.6
Sun, H.7
El-Naggar, A.K.8
Xing, M.9
-
8
-
-
1942470097
-
Mutational analysis of BRAF in fine needle aspiration biopsies of the thyroid: A potential application for the preoperative assessment of thyroid nodules
-
Cohen Y, Rosenbaum E, Clark DP, Zeiger MA, Umbricht CB, Tufano RP, Sidransky D, Westra WH 2004 Mutational analysis of BRAF in fine needle aspiration biopsies of the thyroid: a potential application for the preoperative assessment of thyroid nodules. Clin Cancer Res 10:2761-2765.
-
(2004)
Clin Cancer Res
, vol.10
, pp. 2761-2765
-
-
Cohen, Y.1
Rosenbaum, E.2
Clark, D.P.3
Zeiger, M.A.4
Umbricht, C.B.5
Tufano, R.P.6
Sidransky, D.7
Westra, W.H.8
-
9
-
-
0037379904
-
High prevalence of BRAF mutations in thyroid cancer: Genetic evidence for constitutive activation of the RET/PTC-RAS-BRAF signaling pathway in papillary thyroid carcinoma
-
Kimura ET, Nikiforova MN, Zhu Z, Knauf JA, Nikiforov YE, Fagin JA 2003 High prevalence of BRAF mutations in thyroid cancer: genetic evidence for constitutive activation of the RET/PTC-RAS-BRAF signaling pathway in papillary thyroid carcinoma. Cancer Res 63:1454-1457.
-
(2003)
Cancer Res
, vol.63
, pp. 1454-1457
-
-
Kimura, E.T.1
Nikiforova, M.N.2
Zhu, Z.3
Knauf, J.A.4
Nikiforov, Y.E.5
Fagin, J.A.6
-
10
-
-
84875952085
-
Association between BRAF V600E mutation and mortality in patients with papillary thyroid cancer
-
Xing M, Alzahrani AS, Carson KA, Viola D, Elisei R, Bendlova B, Yip L, Mian C, Vianello F, Tuttle RM, Robenshtok E, Fagin JA, Puxeddu E, Fugazzola L, Czarniecka A, Jarzab B, O'Neill CJ, Sywak MS, Lam AK, Riesco-Eizaguirre G, Santisteban P, Nakayama H, Tufano RP, Pai SI, Zeiger MA, Westra WH, Clark DP, Clifton-Bligh R, Sidransky D, Ladenson PW, Sykorova V 2013 Association between BRAF V600E mutation and mortality in patients with papillary thyroid cancer. JAMA 309:1493-1501.
-
(2013)
JAMA
, vol.309
, pp. 1493-1501
-
-
Xing, M.1
Alzahrani, A.S.2
Carson, K.A.3
Viola, D.4
Elisei, R.5
Bendlova, B.6
Yip, L.7
Mian, C.8
Vianello, F.9
Tuttle, R.M.10
Robenshtok, E.11
Fagin, J.A.12
Puxeddu, E.13
Fugazzola, L.14
Czarniecka, A.15
Jarzab, B.16
O'Neill, C.J.17
Sywak, M.S.18
Lam, A.K.19
Riesco-Eizaguirre, G.20
Santisteban, P.21
Nakayama, H.22
Tufano, R.P.23
Pai, S.I.24
Zeiger, M.A.25
Westra, W.H.26
Clark, D.P.27
Clifton-Bligh, R.28
Sidransky, D.29
Ladenson, P.W.30
Sykorova, V.31
more..
-
11
-
-
84883711485
-
Frequent somatic TERT promoter mutations in thyroid cancer: Higher prevalence in advanced forms of the disease
-
Landa I, Ganly I, Chan TA, Mitsutake N, Matsuse M, Ibrahimpasic T, Ghossein RA, Fagin JA 2013 Frequent somatic TERT promoter mutations in thyroid cancer: higher prevalence in advanced forms of the disease. J Clin Endocrinol Metab 98:E1562-1566.
-
(2013)
J Clin Endocrinol Metab
, vol.98
, pp. E1562-1566
-
-
Landa, I.1
Ganly, I.2
Chan, T.A.3
Mitsutake, N.4
Matsuse, M.5
Ibrahimpasic, T.6
Ghossein, R.A.7
Fagin, J.A.8
-
12
-
-
84899908886
-
TERT promoter mutations are a major indicator of poor outcome in differentiated thyroid carcinomas
-
Melo M, da Rocha AG, Vinagre J, Batista R, Peixoto J, Tavares C, Celestino R, Almeida A, Salgado C, Eloy C, Castro P, Prazeres H, Lima J, Amaro T, Lobo C, Martins MJ, Moura M, Cavaco B, Leite V, Cameselle-Teijeiro JM, Carrilho F, Carvalheiro M, Maximo V, Sobrinho-Simoes M, Soares P 2014 TERT promoter mutations are a major indicator of poor outcome in differentiated thyroid carcinomas. J Clin Endocrinol Metab 99:E754-765.
-
(2014)
J Clin Endocrinol Metab
, vol.99
, pp. E754-765
-
-
Melo, M.1
Da Rocha, A.G.2
Vinagre, J.3
Batista, R.4
Peixoto, J.5
Tavares, C.6
Celestino, R.7
Almeida, A.8
Salgado, C.9
Eloy, C.10
Castro, P.11
Prazeres, H.12
Lima, J.13
Amaro, T.14
Lobo, C.15
Martins, M.J.16
Moura, M.17
Cavaco, B.18
Leite, V.19
Cameselle-Teijeiro, J.M.20
Carrilho, F.21
Carvalheiro, M.22
Maximo, V.23
Sobrinho-Simoes, M.24
Soares, P.25
more..
-
13
-
-
84906815246
-
BRAF V600E and TERT promoter mutations cooperatively identify the most aggressive papillary thyroid cancer with highest recurrence
-
Xing M, Liu R, Liu X, Murugan AK, Zhu G, Zeiger MA, Pai S, Bishop J 2014 BRAF V600E and TERT promoter mutations cooperatively identify the most aggressive papillary thyroid cancer with highest recurrence. J Clin Oncol 32:2718-2726.
-
(2014)
J Clin Oncol
, vol.32
, pp. 2718-2726
-
-
Xing, M.1
Liu, R.2
Liu, X.3
Murugan, A.K.4
Zhu, G.5
Zeiger, M.A.6
Pai, S.7
Bishop, J.8
-
14
-
-
84908335908
-
Integrated genomic characterization of papillary thyroid carcinoma
-
Network CGAR
-
Network CGAR 2014 Integrated genomic characterization of papillary thyroid carcinoma. Cell 159:676-690.
-
(2014)
Cell
, vol.159
, pp. 676-690
-
-
-
15
-
-
70449370231
-
Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer
-
American Thyroid Association Guidelines Taskforce on Thyroid N, Differentiated Thyroid C
-
American Thyroid Association Guidelines Taskforce on Thyroid N, Differentiated Thyroid C, Cooper DS, Doherty GM, Haugen BR, Kloos RT, Lee SL, Mandel SJ, Mazzaferri EL, McIver B, Pacini F, Schlumberger M, Sherman SI, Steward DL, Tuttle RM 2009 Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 19:1167-1214.
-
(2009)
Thyroid
, vol.19
, pp. 1167-1214
-
-
Cooper, D.S.1
Doherty, G.M.2
Haugen, B.R.3
Kloos, R.T.4
Lee, S.L.5
Mandel, S.J.6
Mazzaferri, E.L.7
McIver, B.8
Pacini, F.9
Schlumberger, M.10
Sherman, S.I.11
Steward, D.L.12
Tuttle, R.M.13
|